Question follow-through · 22273
ME/CFS: Diagnosis
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that NICE's recognition of post-exertional malaise as a core diagnostic feature of ME/CFS is reflected consistently in (a) clinical training and (b) NHS service p
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 28 Aug 2026
- Target answer date
- 2 Sept 2026
- Answer
- 14 Sept 2026 · 17 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- National Institute for Health and Care Research · 2 Sept 2026
- Cancer: Medical Treatments · 3 Sept 2026
- Blood Cancer: Health Services · 4 Sept 2026
- Rare Cancers: Health Services · 4 Sept 2026
- Prescription Drugs: Sugar and Artificial Sweeteners · 4 Sept 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
28 Aug 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that NICE's recognition of post-exertional malaise as a core diagnostic feature of ME/CFS is reflected consistently in (a) clinical training and (b) NHS service p
2 Sept 2026
Target answer date
Date supplied by the official written-questions record.
14 Sept 2026
Answer published
I refer the Hon Member to the answer provided to the Hon Member for Skipton and Ripon on 16 July 2026 to Question 16893.Additionally, the Department, together with NHS England, have developed a template service specification for mild, moderate, and severe...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
National Institute for Health and Care Research
2 Sept 2026 · To ask the Secretary of State for Health and Social Care, what steps her department is taking to improve existing arrangements, or to develop new policy and funding mechanisms, to support the National Institute for Health and Care Research (NIHR).
Cancer: Medical Treatments
3 Sept 2026 · To ask the Secretary of State for Health and Social Care, what steps her Department is taking to prioritise access to special treatment for patients with rare cancers such as lymphoma and expand access to specialist expertise.
Blood Cancer: Health Services
4 Sept 2026 · To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that blood cancers, including lymphoma, are prioritised along with other rare and less common cancers.
Rare Cancers: Health Services
4 Sept 2026 · To ask the Secretary of State for Health and Social Care, what progress her Department is making on measuring and reporting progress against commitments with regard to people with rare and less common cancers.
Prescription Drugs: Sugar and Artificial Sweeteners
4 Sept 2026 · To ask the Secretary of State for Health and Social Care, if her Department will issue guidance or instructions relating to the reduction or removal of sugar from prescription medicines; and if she will make an assessment of the potential impact of such c
Prescription Drugs: Sugar and Artificial Sweeteners
4 Sept 2026 · To ask the Secretary of State for Health and Social Care, if her Department will take steps to ensure the continued availability of prescription medicines which do not contain artificial sweeteners for patients with adverse reactions to those substances.
Colestyramine: Prescriptions
4 Sept 2026 · To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of the reported withdrawal of the original formulation of Questran from the UK market on patients with bile acid malabsorption.
NHS: Software
10 Sept 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the compatibility of IT systems used by primary care providers with the NHS App and systems used in secondary care; and what steps his Department is taking to improve
Medicine: Universities
14 Sept 2026 · To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of redundancies among university-employed clinical academics on NHS clinical capacity; how many NHS programmed activities are current
Medicine: Universities
14 Sept 2026 · To ask the Secretary of State for Health and Social Care, what discussions her Department has had with the Department for Education concerning the withdrawal of Strategic Priorities Grant support for clinical academic pay, and what assessment has been mad
Medicine: Universities
14 Sept 2026 · To ask the Secretary of State for Health and Social Care, whether her Department has discussed with Nottingham University Hospitals NHS Trust and the University of Nottingham the potential effect of the Future Nottingham restructuring programme on the num